Pick a time period -
No more available filters You need to apply a filter before selecting newsroom

Use our filters to get your customized news. Save and subscribe to as many filters as you want, get the news that YOU are interested in right in your mailbox, RSS feed or in your personalized dashboard. Share your stories, news, multimedia and pressreleases and get a wider audience with news.cision.com.

Episurf Medical enters into international advisory agreement

Episurf Medical (Nasdaq: EPIS B) today announces that the company has entered into an advisory agreement with Prof. Doctor João Espregueira-Mendes regarding establishment of the Episealer® knee technology in India and Portugal. The parties will work with a targeted strategy, targeting the orthopaedic communities in the aforementioned countries. Prof. Doctor João Espregueira-Mendes has extensive experience from the global orthopaedic markets and will assist Episurf Medical in key strategic activities. Prof. Doctor João Espregueira-Mendes is the Clinical Director of Clínica do Dragão -

Lehto Group Plc: Managers' Transactions

Lehto Group PlcManagers' Transactions November 27, 2020 at 3.07 p.m. (EET)Lehto Group Oyj - Managers' Transactions ____________________________________________ Person subject to the notification requirement Name: Heikkilä, Jaakko Position: Other senior manager Issuer: Lehto Group Oyj LEI: 743700YEHY9I3ZDHNX66 Notification type: INITIAL NOTIFICATION Reference number: 743700YEHY9I3ZDHNX66_20201127130010_4 ____________________________________________ Transaction date: 2020-11-25 Venue: NASDAQ HELSINKI LTD (XHEL) Instrument type: FINANCIAL INSTRUMENT

Lehto Group Plc: Managers' Transactions

Lehto Group PlcManagers' Transactions November 27, 2020 at 3.06 p.m. (EET)Lehto Group Oyj - Managers' Transactions ____________________________________________ Person subject to the notification requirement Name: Räsänen, Mikko Position: Member of the Board/Deputy member Issuer: Lehto Group Oyj LEI: 743700YEHY9I3ZDHNX66 Notification type: INITIAL NOTIFICATION Reference number: 743700YEHY9I3ZDHNX66_20201127121446_3 ____________________________________________ Transaction date: 2020-11-26 Venue not applicable Instrument type: SHARE ISIN: FI4000081138

Lehto Group Plc: Managers' Transactions

Lehto Group PlcManagers' Transactions November 27, 2020 at 3.05 p.m. (EET)Lehto Group Oyj - Managers' Transactions ____________________________________________ Person subject to the notification requirement Name: Törrönen, Kaarle Position: Other senior manager Issuer: Lehto Group Oyj LEI: 743700YEHY9I3ZDHNX66 Notification type: INITIAL NOTIFICATION Reference number: 743700YEHY9I3ZDHNX66_20201127122112_4 ____________________________________________ Transaction date: 2020-11-25 Venue not applicable Instrument type: SHARE ISIN: FI4000081138 Nature

Lehto Group Plc: Managers' Transactions

Lehto Group PlcManagers' Transactions November 27, 2020 at 3.04 p.m. (EET)Lehto Group Oyj - Managers' Transactions ____________________________________________ Person subject to the notification requirement Name: Reiniluoto, Timo Position: Other senior manager Issuer: Lehto Group Oyj LEI: 743700YEHY9I3ZDHNX66 Notification type: INITIAL NOTIFICATION Reference number: 743700YEHY9I3ZDHNX66_20201127122032_6 ____________________________________________ Transaction date: 2020-11-25 Venue not applicable Instrument type: SHARE ISIN: FI4000081138 Nature

Lehto Group Plc: Managers' Transactions

Lehto Group PlcManagers' Transactions November 27, 2020 at 3.03 p.m. (EET)Lehto Group Oyj - Managers' Transactions ____________________________________________ Person subject to the notification requirement Name: Säteri, Helena Position: Member of the Board/Deputy member Issuer: Lehto Group Oyj LEI: 743700YEHY9I3ZDHNX66 Notification type: INITIAL NOTIFICATION Reference number: 743700YEHY9I3ZDHNX66_20201127121903_4 ____________________________________________ Transaction date: 2020-11-25 Venue not applicable Instrument type: SHARE ISIN: FI4000081138

Lehto Group Plc: Managers' Transactions

Lehto Group PlcManagers' Transactions November 27, 2020 at 3.02 p.m. (EET)Lehto Group Oyj - Managers' Transactions ____________________________________________ Person subject to the notification requirement Name: Lehtiö, Raimo Position: Member of the Board/Deputy member Issuer: Lehto Group Oyj LEI: 743700YEHY9I3ZDHNX66 Notification type: INITIAL NOTIFICATION Reference number: 743700YEHY9I3ZDHNX66_20201127121802_4 ____________________________________________ Transaction date: 2020-11-25 Venue not applicable Instrument type: SHARE ISIN: FI4000081138

Lehto Group Plc: Managers' Transactions

Lehto Group PlcManagers' Transactions November 27, 2020 at p.m. 3.01 p.m. (EET)Lehto Group Oyj - Managers' Transactions ____________________________________________ Person subject to the notification requirement Name: Korkiakoski, Anne Position: Member of the Board/Deputy member Issuer: Lehto Group Oyj LEI: 743700YEHY9I3ZDHNX66 Notification type: INITIAL NOTIFICATION Reference number: 743700YEHY9I3ZDHNX66_20201127121702_4 ____________________________________________ Transaction date: 2020-11-25 Venue not applicable Instrument type: SHARE ISIN:

Lehto Group Plc: Managers' Transactions

Lehto Group PlcManagers' Transactions November 27, 2020 at 3.00 p.m. (EET)Lehto Group Oyj - Managers' Transactions ____________________________________________ Person subject to the notification requirement Name: Laine, Seppo Position: Member of the Board/Deputy member Issuer: Lehto Group Oyj LEI: 743700YEHY9I3ZDHNX66 Notification type: INITIAL NOTIFICATION Reference number: 743700YEHY9I3ZDHNX66_20201127121542_4 ____________________________________________ Transaction date: 2020-11-25 Venue not applicable Instrument type: SHARE ISIN: FI4000081138

Qlife will not respond to preliminary rejection by the Danish Medicines Agency for COVID-19 test – focus on receiving CE-marking by year-end

Qlife has decided not to respond to the preliminary announcement from the Danish Medicines Agency (Lægemiddelstyrelsen) regarding the rejection of the company’s application for temporay approval in Denamark “in the interest of health protection” for the company’s COVID-19 test. The company will instead focus on completing the documentation for CE-marking in accordance with the timeline previously communicated. Qlife expects CE-marking at the turn of the year 2020/2021.On November 13, Qlife was informed that the Danish Medicines Agency (Lægemiddelstyrelsen) had rejected the application for

Bittium Corporation’s Strategy and Long-Term Financial Targets

Stock Exchange Release Free for publication on November 27, 2020 at 2.47 p.m. (CET+1) Bittium Corporation’s Strategy and Long-Term Financial Targets Bittium aims to be a significant global provider of secure and safe communication solutions in the defense and public safety markets, and a leading provider of connectivity solutions and R&D services for different industries, as well as a significant provider of remote measuring and diagnostics solutions for measuring and analyzing biosignals. Five years ago, Bittium Corporation updated its strategy in order to strengthen its position

Bittium Corporation’s Board of Directors Has Decided That No Dividend Will Be Paid for 2019

Stock Exchange Release Free for publication on November 27, 2020 at 2.46 p.m. (CET+1) Bittium Corporation’s Board of Directors Has Decided That No Dividend Will Be Paid for 2019 Under the authorization of the Annual General Meeting held on June 15, 2020, the Board of Directors of Bittium Corporation has decided today, that no dividend based on the distributable assets of the adopted balance sheet for the financial period of January 1, 2019 - December 31, 2019 shall be paid. This decision strengthens the company’s ability to invest in line with its strategy to enable future growth.

Bittium Corporation Lowers Its Financial Outlook for 2020

Stock Exchange Release Free for publication on November 27, 2020 at 2.45 p.m. (CET+1) Bittium Corporation Lowers Its Financial Outlook for 2020 Bittium Corporation lowers its financial outlook for 2020. The company expects that the net sales in 2020 will be at the same level or grow from the previous year (EUR 75.2 million in 2019), and the operating result will be lower than in the previous year (EUR 6.3 million in 2019). Earlier, Bittium expected that the net sales in 2020 will grow from the previous year (EUR 75.2 million in 2019) and the operating result will be at the same

SAPA launches sliding door using extremely slim profiles

SAPA is now launching a sleek, high-quality lift-and-slide door that elegantly combines slim profiles with a high level of airtightness and excellent thermal properties. The most important feature of this design is also the least visible: its narrow centre profile. These slim profiles allow a minimalist design approach and let in even more of that all-important daylight.   Minimalist design adapted for the Nordic climate    The construction is based on the classic 2160S door, using extra-slim profiles to create 2160S XS. The sliding door is fabricated from insulating aluminium

Report from Epiroc AB’s Extraordinary General Meeting

Stockholm, Sweden: Epiroc AB’s Extraordinary General Meeting (EGM) held today approved the proposed second dividend of SEK 1.20 per share.The record date will be December 1, 2020, and the second dividend is expected to be distributed by Euroclear Sweden AB on December 4, 2020.  The EGM also approved the proposals to amend Epiroc AB’s articles of association so that the Board of Directors ahead of future General Meetings is able to decide on the collection of proxy votes and the opportunity for voting by mail. Due to the Covid-19 pandemic and the related restrictions, and in accordance

Inzile delivers four electric trucks to Bring for fossil-free home deliveries starting on Black Friday

Inzile delivers four electric trucks to Bring of the new model Pro4 Max. The first Inzile vehicle was delivered in June this year and has worked out well in Bring's operations. The four new electric vehicles will also be used for fossil-free home deliveries in urban environments.The four light trucks delivered from Inzile are the continuation of the collaboration with Bring, which began with the delivery of a first electric truck in June this year. Posten Norge, of which Bring is a part, owns about five percent of Inzile. Bring has so far ordered five trucks from Inzile. Inzile and Bring

NPRO: Approval and publication of prospectus

NOT FOR DISTRIBUTION OR RELEASE, IN WHOLE OR IN PART, DIRECTLY OR INDIRECTLY, IN OR INTO THE UNITED STATES OF AMERICA, AUSTRALIA, CANADA, THE HONG KONG SPECIAL ADMINISTRATIVE REGION OF THE PEOPLE'S REPUBLIC OF CHINA OR JAPAN, OR ANY OTHER JURISDICTION IN WHICH THE DISTRIBUTION OR RELEASE WOULD BE UNLAWFUL   Reference is made to the stock exchange announcement from Norwegian Property ASA (the "Company") on 23 August 2020, regarding key information relating to a potential subsequent offering, and 9 November 2020 regarding completion of the NOK 557 million private placement. The

Vestas wins 40 MW order in Poland

News release from Vestas Northern and Central EuropeHamburg, 27 November 2020 Vestas has secured a 40 MW order for the Nowy Tomysl project from SPV Sevivon Windpark 2 Sp. Z.o.o., a subsidiary of leading European project developer PNE AG. Located in Kuslin in western Poland, the project will consist of 12 V126-3.45 MW wind turbines in 3.3 MW operating mode combined with 137m towers, maximising power production while at the same time offering competitive levelised cost of energy. Adding to the more than 1.5 GW of contracts signed in Poland’s auction system to date, this order

Asetek - Share Capital Increase Upon Exercise of Warrants

Reference is made to warrants issued by Asetek A/S, Danish central business register (CVR) no. 34880522 (the "Company"), pursuant to corporate resolutions adopted on August 12, 2014, August 11, 2015, April 28, 2016, and April 25, 2017 respectively. Pursuant to the applicable warrant terms, the warrants are exercisable in exercise windows open in a four weeks period running from the Company's preliminary announcement of its financial statements or publication of its interim financial report however no later than 7 years after the Subscription Date as specified in the Subscription

Sedana Medical submits market approval application for the drug Sedaconda

Sedana Medical AB (publ) (SEDANA: FN Stockholm) today announced that the company has submitted an application for market approval for the drug candidate Sedaconda (isoflurane), formerly known as IsoConDa, for inhaled sedation in intensive care. The application has been submitted to the German Medicines Agency BfArM and a number of other European Medicines Agencies through a so-called DCP procedure.The application is the starting point of the review process of Sedaconda in 15 of the EU member states, including Norway. If all goes well, Sedana Medical expects an approval in the second half of

Innovations for a better future: Fazer’s xylitol factory awarded the Finnish Star Act 2020

Fazer is The Food Experience Company, and by investing in innovations and Foodtech, Fazer strengthens its focus on the sustainable food solutions of the future. Fazer’s strategic focus on innovations has been recognised by the Finnish Food and Drink Industries’ Federation, which awarded Fazer’s xylitol factory as Star Act 2020 (Tähtiteko) on 27 November.  Innovations at the core of Fazer’s strategy  Sustainability in food and nutrition is high on Fazer’s agenda, and Fazer sees innovations as a key enabler in executing its strategy.“We see food as a solution. How we grow, produce and

Introduction of RayIntelligence and the latest releases of RayStation and RayCare at ESTRO 2020

RaySearch Laboratories AB (publ) will reveal its latest advances in oncology software at ESTRO 2020 from November 28 through December 1, 2020. Attendees can book personal online demos of treatment planning system RayStation®* and oncology information system RayCare®*. Cloud-based oncology analytics system RayIntelligence® will be presented during RaySearch Digital Satellite Symposia. The latest release of RayStation, 10B, is expected in December 2020. New functionalities in the release now include support for brachytherapy planning with automatic channel reconstruction and

Correction to the Qt Group Plc's Annual General Meeting material publication date on the company's website

Stock Exchange Release November 27, 2020 at 1 pm The stock exchange release published by Qt Group Plc on November 24, 2020 incorrectly states that "The AGM material will be available on the company's website at www.qt.io on February 17, 2021." The correct date for the material's release will be February 18, 2021. Therefore, the material related to the Annual General Meeting will be available on the company's website www.qt.io as of February 18, 2021.    DISTRIBUTIONNasdaq HelsinkiPrincipal mediawww.qt.io

There are no items matching the current filter
There are no more items matching the current filter
Back to top